HIV Malignancy Specimens for Research at No Charge
FOA Number: RFA-CA-20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance …
Notice Number NOT-CA-20-098 Notice of Intent to Publish a Funding Opportunity Announcement for Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) The National Cancer Institute …
Funding Opportunity Announcement (FOA) Number PAR-20-106 The purpose of this Funding Opportunity Announcement (FOA) PAR-20-106 is to invite applications for the Centers for AIDS Research (CFAR) program-to provide administrative and …
Notice Number: NOT-AI-20-034 Key DatesRelease Date: March 25, 2020First Available Due Date: March 25, 2020Expiration Date: March 25, 2021 Related AnnouncementsNOT-AI-20-040PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) …
The fellowship program was established to encourage and foster the development of new and junior clinical investigators at our domestic and international sites to pursue careers in clinical research trials …
For more information about this potential funding opportunity, please check out the Office of HIV and AIDS Malignancy’s presentation of the FOA Concept to the Board of Scientific Advisors on …
The Conquer Cancer Foundation (CCF) of ASCO is accepting applications for the inaugural 2018 Global Oncology Young Investigator Award (YIA). The one-year grant provides research funding to early-career investigators to …
The purpose of this Funding Opportunity Announcement (FOA) is to advance our understanding of the role of the tumor niche or microenvironment in the risks, development, progression, diagnosis, and treatment …
Completed 2017 YOUNG INVESTIGATOR PILOT AWARD APPLICATIONS are due by 5pm PDT on February 17, 2017. Applications should be submitted as pdf documents to CODCC@acsr1.com(READ MORE)